Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would de...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinks, Crystal B, Zidan, Ahmed S, Khan, Mansoor A, Habib, Muhammad J, Faustino, Patrick J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327912/
https://www.ncbi.nlm.nih.gov/pubmed/28260952
http://dx.doi.org/10.2147/CPAA.S119875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327912/
https://www.ncbi.nlm.nih.gov/pubmed/28260952
http://dx.doi.org/10.2147/CPAA.S119875

Ejemplares similares